Amgen stock holds above key SMAs as strong drug sales, biosimilars, and MariTide pipeline momentum offset looming patent losses and pricing headwinds.

Someone asked “Doctors, what were the wildest self-diagnoses a patient was actually right about?” and people shared their ...

Among adults with chronic rhinosinusitis with nasal polyps, those receiving verekitug vs. placebo at baseline and week 12 had significantly decreased nasal polyp size at week 24, according to a poster ...

Technology is changing how doctors detect colon cancer. New AI-enhanced imaging tools help physicians find subtle polyps that ...

Allergy season is upon us, bringing with it runny noses, itchy eyes and sneezing. Climate change is leading to longer and ...

When Kevin Tougher was diagnosed with nasal cavity cancer at 39, he faced the possibility of losing his nose to surgery. A groundbreaking treatment at MSK changed everything—preserving both his health ...

Transaction adds TYMLOS® to portfolio alongside NUZYRA® and XHANCE® and creates a diversified portfolio expected to generate nearly $1 billion in revenue in 2026 KING OF PRUSSIA, Pa., March 18, 2026 ...

COLUMBUS, Ga. (WRBL) — Dr. Vipin Matthew from Piedmont Columbus Regional stopped by WRBL News 3 Mornings to discuss the spike doctors are seeing this pollen season. Dr. Matthew says he is seeing an ...

Plus, all of the surprising potential side effects of doing it wrong.

Eli Lilly and Company (NYSE: LLY) today announced positive, topline results from the Phase 3 ADorable-1 trial evaluating the safety and efficacy of EBGLYSS (lebrikizumab-lbkz) in pediatric patients ...

I had breast cancer in my left breast 14 years ago. I was treated with chemotherapy and radiation after a lumpectomy and the removal of 14 lymph ...

A wave of oak pollen is driving one of the worst stretches of allergy season in Louisiana. Here’s what’s behind it, how long it will last and how to find relief.